bioMérieux is a global leader in in vitro diagnostics providing diagnostics solutions that improve patient health and ensure consumer safety.
Investment highlights
1890
Year of establishment
France
Country
2009
Year of entry
1.00%
Shareholding percentage *
Healthcare and life sciences
Sector
* Sofina is represented in the decision-making bodies of the company.
bioMérieux is headquartered in Marcy-l’Etoile, France. The teams of Sofina and Institut Mérieux know each other since 2003, six years before the investment, which allowed the creation of a strong trust relationship ahead of the investment of 2009. Since then, the relationship has strengthened through the participation at meetings of the board and the audit committee chaired by the board member nominated by Sofina.